

* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug


(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...


(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.


(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Sharecast News) - Xaar reported a return to profitability on an adjusted basis for 2025 on Tuesday, as revenue growth in its core printhead business ...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:


(Alliance News) - Harbour Energy says it has been made operator of an asset in Mexico, while Digital 9 says the bulk of the proceeds from the sale of ...